Showing results (41-50 of 499) with videos related to
Sort By:
Pageof 50
British Medical Journal|October 4, 1975
Aminocaproic acid and menstrual loss in women using intrauterine devicesJ M Kasonde, J BonnarBritish Journal of Obstetrics and Gynaecology|July 1, 1976
Effect of sterilization on menstrual blood lossJ M Kasonde, J BonnarBritish Journal of Obstetrics and Gynaecology|December 1, 1977
Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancyC A Thornton, J BonnarBailliere'S Clinical Obstetrics and Gynaecology|March 7, 1998
Haemostatic changes and the oral contraceptive pillL A Norris, J BonnarBritish Journal of Obstetrics and Gynaecology|March 1, 1996
The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptivesL A Norris, J BonnarBritish Journal of Haematology|June 1, 1975
Measurement of heparin in patients receiving subcutaneous heparin therapyK W Denson, J BonnarThrombosis and Haemostasis|June 30, 1986
Differences in coagulation and haemostatic parameters in normal women of childbearing age from different ethnic groups and geographical locations. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human ReproductionJ A Bocaz, P Barja, J Bonnar, et al.International Journal of Epidemiology|December 1, 1991
A multicentre study of coagulation and haemostatic variables during oral contraception: variations with geographical location and ethnicity. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human ReproductionI Leck, J M Thomson, J A Bocaz, et al.British Journal of Obstetrics and Gynaecology|April 1, 1976
Plasminogen activators in the endometrium of women using intrauterine contraceptive devicesJ M Kasonde, J BonnarThrombosis and Haemostasis|December 1, 1994
Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptivesL A Norris, J BonnarPageof 50